Back to R2 link
Top Industry News
- CDER’s OGD and EMA’s Parallel Scientific Advice Pilot Program for Complex Generics Works to Increase Harmonization and Bring Generic Drugs to Patients
- Swissmedic Swiss Database on Medical Devices
- EMA Progress Update on Pilot for Academic and Non-Profit Developers of Advanced Therapy Medicines
- Starting from December 31, 2026, the Environmental Protection Authority (EPA) New Zealand has prohibited the inclusion of per- and polyfluoroalkyl substances (PFAS) in cosmetic products
- MHRA Regulating Medical Devices in the UK
- MHRA - Access New Active Substance and Biosimilar Work Sharing Initiatives
- PMDA Guidelines for Promoting Optimal Use of Pharmaceuticals Have Been Published
- Saudi FDA Products Classification Guidance
- PMDA Pharmaceutical and Medical Device Safety Information
- SFDA Guidance on Biotechnology-based Medical Devices (MDS-G016)
- Application for Modification of the Traditional Term 'Fino' in the Wine Sector: European Official Journal Announcement
- SFDA Recognized Standards (Supporting Medical Device Premarket Submissions)
- Recently the Ministry of Food and Drug Safety (MFDS) in South Korea has issued guidelines for establishing residue limits for pesticides and veterinary drugs in food
- MHRA Parallel Import Licences: Lists of Approved Products
- AICIS Published Variation to Inventory listing after evaluation: CAS No. 2370-63-0 and 6976-93-8
- MHRA Parallel Import Licences Granted in 2024
- MHRA Marketing Authorisations: Lists of Granted Licences
- MHRA Marketing Authorisations Granted in 2024
- HSA Regulatory Fee Revision for Health Products
- EC Procedures for the Updates of the European Medical Device Nomenclature
Mergers & Acquisitions
- QSAM Biosciences Signs Definitive Agreement to be Acquired by Telix Pharmaceuticals
- Novo Holdings to Acquire Catalent, Inc
- Novartis to Strengthen Oncology Pipeline with Agreement to Acquire MorphoSys AG
- Jazz Pharmaceuticals Enters Definitive Agreement with Redx Pharma to Acquire Global Rights to KRAS Inhibitor Program
- Immunome to Acquire AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals
- Merck Animal Health to Acquire Elanco’s Aqua Business
- Bruker Acquires Spectral Instruments Imaging, the Performance Leader in Preclinical In-Vivo Optical Imaging Systems
- Bruker Acquires Nanophoton Corporation, a Japanese Technology Leader in Research Raman Microscopy with 20 Years of Experience